FDA approves Alzheimer's drug shown to slow disease progression

The Food and Drug Administration has granted fast-track approval for a new Alzheimer's drug - called lecanemab.

Clinical trials have shown that the drug can moderately slow the progression of the disease, but medical professionals are divided over its safety and how effective it actually is.

Toni Waterman has more.

IN: The FDA said…
DUR: 38s
SOC: sign off
http://www.fsnradionews.com/feeds/0106AlzheimerDrugApproval-tw.mp3